Agenus Newsroom

Express News | Agenus to Provide Corporate Update and First Quarter 2025 Financial Report

ReutersApr 29 07:30 ET

Press Release: Agenus to Provide Corporate Update and First Quarter 2025 Financial Report

Dow JonesApr 29 07:30 ET

Agenus: Initial Results From NEOASIS Show BOT/BAL Efficacy In Neoadjuvant Setting Across Multiple MSS And MSI-H Solid Tumors

BenzingaApr 28 15:32 ET

Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025

Business WireApr 23 12:05 ET

New Analyst Forecast: $AGEN Given 'Buy' Rating

Quiver QuantitativeApr 23 06:33 ET

B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Cuts Target Price to $8

Moomoo NewsApr 22 00:32 ET · Ratings

B. Riley Cuts Price Target on Agenus to $8 From $11, Keeps Buy Rating

MT NewswiresApr 21 08:21 ET · Ratings

Here's Why Agenus (AGEN) Is a Great 'Buy the Bottom' Stock Now

Yahoo FinanceMar 25 09:55 ET

Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation

BusinesswireMar 19 07:30 ET

Agenus | 10-K: FY2024 Annual Report

SECMar 17 16:17 ET · Announcements

Agenus Inc. Earnings Call: Mixed Sentiments and Strategic Focus

TipRanksMar 12 20:20 ET

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating

Moomoo NewsMar 12 11:31 ET · Ratings

Baird Maintains Agenus(AGEN.US) With Hold Rating, Cuts Target Price to $3

Moomoo NewsMar 12 11:31 ET · Ratings

Baird Maintains Neutral on Agenus, Lowers Price Target to $3

BenzingaMar 12 08:25 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Neutral on Agenusto Neutral

BenzingaMar 12 07:20 ET

Agenus Analyst Ratings

BenzingaMar 12 07:18 ET · Ratings

Agenus' Strategic Cost Reductions and CRC Focus Lead to Hold Rating

TipRanksMar 12 06:17 ET

Agenus Inc. Reports Strategic Cost Reductions and BOT/BAL Progress

TipRanksMar 12 00:03 ET

William Blair Maintains Agenus(AGEN.US) With Hold Rating

Moomoo NewsMar 11 13:33 ET · Ratings

Agenus Stock Falls After Revenue Miss

Seeking AlphaMar 11 11:40 ET